Peter Kwasny

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

Peter Albers, Roswitha Siener, S. Krege et al. · Journal of Clinical Oncology · 2008 · 340 citations

Medicine, Oncology, Surgery +14

One course of adjuvant PEB chemotherapy versus retroperitoneal lymph node dissection in patients with stage I non-seminomatous germ-cell tumors (NSGCT): Results of the German Prospective Multicenter Trial (Association of Urological Oncology [AUO]/German Testicular Cancer Study Group [GTCSG] Trial 01–94)

Peter Albers, Roswitha Siener, S. Krege et al. · Journal of Clinical Oncology · 2006 · 25 citations

Medicine, Oncology, Surgery +15

Late toxicities and recurrences in patients with clinical stage I non-seminomatous germ cell tumours after 1 cycle of adjuvant bleomycin, etoposide and cisplatin versus primary retroperitoneal lymph node dissection – A 13-year follow-up analysis of a phase III trial cohort

Andreas Hiester, Anna Fingerhut, Günter Niegisch et al. · European Journal of Cancer · 2021 · 15 citations

Medicine, Oncology, Radiation Oncology +11